We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 4,095 results
  1. SMAD4 variants and its genotype–phenotype correlations to juvenile polyposis syndrome

    Background

    Juvenile polyposis syndrome (JPS), a rare autosomal dominant syndrome, affects one per 100 000 births, increasing lifetime cancer risk by 9...

    Kimberley Cao, John-Paul Plazzer, Finlay Macrae in Hereditary Cancer in Clinical Practice
    Article Open access 08 December 2023
  2. SMAD4 endows TGF-β1-induced highly invasive tumor cells with ferroptosis vulnerability in pancreatic cancer

    Pancreatic ductal adenocarcinoma (PDAC) is an extremely aggressive malignancy prone to recurrence and metastasis. Studies show that tumor cells with...

    Hai-di Chen, Zeng Ye, ... Yi Qin in Acta Pharmacologica Sinica
    Article 06 December 2023
  3. GATA2 co-opts TGFβ1/SMAD4 oncogenic signaling and inherited variants at 6q22 to modulate prostate cancer progression

    Background

    Aberrant somatic genomic alteration including copy number amplification is a hallmark of cancer genomes. We previously profiled genomic...

    **ayun Yang, Qin Zhang, ... Gong-Hong Wei in Journal of Experimental & Clinical Cancer Research
    Article Open access 08 August 2023
  4. Outcomes of patients with Juvenile Polyposis-Hereditary Haemorrhagic Telangiectasia caused by pathogenic SMAD4 variants in a pan-Scotland cohort

    Constitutional loss of SMAD4 function results in Juvenile Polyposis-Hereditary Haemorrhagic Telangiectasia Overlap Syndrome (JP-HHT). A retrospective...

    Madeline Pearson, Ruth McGowan, ... Jonathan Berg in European Journal of Human Genetics
    Article Open access 16 April 2024
  5. SMAD4–201 transcript as a putative biomarker in colorectal cancer

    Background

    Transcripts with alternative 5′-untranslated regions (UTRs) result from the activity of alternative promoters and they can determine gene...

    Tamara Babic, Sandra Dragicevic, ... Aleksandra Nikolic in BMC Cancer
    Article Open access 16 January 2022
  6. Spatiotemporal modulation of SMAD4 by HBx is required for cellular proliferation in hepatitis B-related liver cancer

    Purpose

    Hepatitis B virus (HBV) plays a crucial role in the progression of hepatocellular carcinoma (HCC). It is known that HBV-encoded X protein...

    Wang Chaomin, Niu Wenhao, ... Li Yueguo in Cellular Oncology
    Article 18 June 2022
  7. SMAD4 Gene Analysis in Patients with Early Onset Colorectal Cancer: A Pilot Study

    Abstract

    In colorectal cancer (CRC), inactivation of SMAD4 occurs early in the disease development and SMAD4 represents one of key driver genes in...

    Aleksandra Nikolic, Jovana Despotovic, ... Dragica Radojkovic in Cytology and Genetics
    Article 16 June 2022
  8. Selective targeting BMP2 and 4 in SMAD4 negative esophageal adenocarcinoma inhibits tumor growth and aggressiveness in preclinical models

    Purpose

    Abnormalities within the Sonic Hedgehog (SHH), Bone Morphogenetic Protein (BMP) and SMAD4 signalling pathways have been associated with the...

    Shulin Li, Sanne J. M. Hoefnagel, ... Kausilia K. Krishnadath in Cellular Oncology
    Article Open access 28 July 2022
  9. HPV-mediated regulation of SMAD4 modulates the DNA damage response in head and neck cancer

    Background

    Head and Neck cancer (HNC) is a fatal malignancy with poor prognosis. Human Papillomavirus (HPV) infection is becoming the prominent cause...

    Simona Citro, Claudia Miccolo, ... Susanna Chiocca in Journal of Experimental & Clinical Cancer Research
    Article Open access 10 February 2022
  10. Large-Scale Proteomics Data Reveal Integrated Prognosis-Related Protein Signatures and Role of SMAD4 and RAD50 in Prognosis and Immune Infiltrations of Prostate Cancer Microenvironment

    As prostate cancer (PCa) is one of the most commonly diagnosed cancer worldwide, identifying potential prognostic biomarkers is crucial. In this...

    Aihetaimujiang Anwaier, Shu-Xuan Zhu, ... Ding-Wei Ye in Phenomics
    Article 27 September 2022
  11. Statin use is associated with a reduced incidence of colorectal cancer expressing SMAD4

    Background

    Long-term use of statins is associated with a small reduced risk of colorectal cancer but their mechanism of action is not well understood....

    Sarah Ouahoud, Rutger J. Jacobs, ... James C. H. Hardwick in British Journal of Cancer
    Article 26 October 2021
  12. Silencing of UBE2D1 inhibited cell migration in gastric cancer, decreasing ubiquitination of SMAD4

    Background

    Gastric cancer (GC) is the second leading cause of cancer-related deaths. Because it is hard to diagnose at early stage, the overall...

    Honghu **e, Yu He, ... Qicheng Lu in Infectious Agents and Cancer
    Article Open access 07 November 2021
  13. Juvenile polyposis diagnosed with an integrated histological, immunohistochemical and molecular approach identifying new SMAD4 pathogenic variants

    Juvenile polyposis (JP) is a rare familial syndrome characterized by the development of numerous hamartomatous polyps of the gastrointestinal tract...

    Andrea Mafficini, Lodewijk A. A. Brosens, ... Claudio Luchini in Familial Cancer
    Article Open access 25 January 2022
  14. SMAD4 haploinsufficiency in small intestinal neuroendocrine tumors

    Background

    Patients with small intestinal neuroendocrine tumors (SINETs) frequently present with lymph node and liver metastases at the time of...

    Tobias Hofving, Erik Elias, ... Yvonne Arvidsson in BMC Cancer
    Article Open access 28 January 2021
  15. Circular RNA hsa_circ_0004872 inhibits gastric cancer progression via the miR-224/Smad4/ADAR1 successive regulatory circuit

    Background

    Emerging evidence has shown that circular RNAs (circRNAs) play a crucial regulatory role in the occurrence and development of cancer....

    Cunying Ma, **aoying Wang, ... Zhifang Liu in Molecular Cancer
    Article Open access 10 November 2020
  16. LncRNA NEAT1 promotes proliferation, migration, invasion and epithelial-mesenchymal transition process in TGF-β2-stimulated lens epithelial cells through regulating the miR-486-5p/SMAD4 axis

    Background

    Abnormal proliferation, metastasis and epithelial-mesenchymal transformation (EMT) of lens epithelial cells (LECs) are direct factors of...

    Huajun Wang, Guangying Zheng in Cancer Cell International
    Article Open access 31 October 2020
  17. MiR-146a reduces fibrosis after glaucoma filtration surgery in rats

    Purpose

    To explore the impact of microRNA 146a (miR-146a) and the underlying mechanisms in profibrotic changes following glaucoma filtering surgery...

    Ruiqi Han, Huimin Zhong, ... Yisheng Zhong in Journal of Translational Medicine
    Article Open access 08 May 2024
  18. SALL1 enforces microglia-specific DNA binding and function of SMADs to establish microglia identity

    Spalt-like transcription factor 1 (SALL1) is a critical regulator of organogenesis and microglia identity. Here we demonstrate that disruption of a...

    Bethany R. Fixsen, Claudia Z. Han, ... Christopher K. Glass in Nature Immunology
    Article Open access 15 June 2023
  19. Whole genome sequencing and disease pattern in patients with juvenile polyposis syndrome: a nationwide study

    Juvenile polyposis syndrome (JPS) is a hereditary hamartomatous polyposis syndrome characterized by gastrointestinal juvenile polyps and increased...

    Anne Marie Jelsig, Thomas van Overeem Hansen, ... John Gásdal Karstensen in Familial Cancer
    Article Open access 24 June 2023
  20. SMAD4 Y353C promotes the progression of PDAC

    Background

    SMAD4 is frequently inactivated and associated with a poor prognosis in pancreatic ductal adenocarcinoma (PDAC). Abnormal SMAD4 expression...

    Zusen Wang, Yongxing Li, ... **aoming **ng in BMC Cancer
    Article Open access 04 November 2019
Did you find what you were looking for? Share feedback.